<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Portland Oregon Personal Injury and Class Action Attorney – Lawyer – Paul and Sugerman PC &#187; FDA</title>
	<atom:link href="http://www.pspc.com/category/fda/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pspc.com</link>
	<description>David vs. Goliath view from Oregon trial lawyers at Paul &#38; Sugerman, PC</description>
	<lastBuildDate>Fri, 01 Jan 2010 03:16:57 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>FDA: Don&#8217;t take Hydroxycut</title>
		<link>http://www.pspc.com/2009/05/fda-dont-take-hydroxycut</link>
		<comments>http://www.pspc.com/2009/05/fda-dont-take-hydroxycut#comments</comments>
		<pubDate>Fri, 01 May 2009 16:29:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[Oregon injury attorney]]></category>
		<category><![CDATA[safety]]></category>
		<category><![CDATA[sugerman]]></category>
		<category><![CDATA[Hydroxycut]]></category>

		<guid isPermaLink="false">http://www.pspc.com/?p=318</guid>
		<description><![CDATA[The FDA issued a warning today today  that consumers should not take the diet supplement Hydroxycut due to its potential to cause liver damage. Here is a link to the FDA notice. 
I&#8217;ve been down this road before in the ephedra litigation. One of the things that would shock most consumers is that many over-the-counter [...]]]></description>
		<wfw:commentRss>http://www.pspc.com/2009/05/fda-dont-take-hydroxycut/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Insulin syringe recall</title>
		<link>http://www.pspc.com/2008/11/insulin-syringe-recall</link>
		<comments>http://www.pspc.com/2008/11/insulin-syringe-recall#comments</comments>
		<pubDate>Thu, 06 Nov 2008 19:57:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[New York Times]]></category>
		<category><![CDATA[Portland personal injury lawyer]]></category>
		<category><![CDATA[product safety]]></category>
		<category><![CDATA[safety]]></category>
		<category><![CDATA[sugerman]]></category>
		<category><![CDATA[insulin syringe]]></category>
		<category><![CDATA[product recall]]></category>

		<guid isPermaLink="false">http://www.pspc.com/?p=248</guid>
		<description><![CDATA[This one sent a bit of a chill down my spine, as I have a number of friends, clients, and acquaintances who are insulin-dependent diabetics. Apparently, a labelling error by Covidien, Ltd. has led to a recall of over 400,000 disposable syringes. The error reportedly could result in insulin doses more than double the intended [...]]]></description>
		<wfw:commentRss>http://www.pspc.com/2008/11/insulin-syringe-recall/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA preemption: Kleptocrats neglected to mention&#8230;.</title>
		<link>http://www.pspc.com/2008/10/fda-preemption-kleptocrats-neglected-to-mention</link>
		<comments>http://www.pspc.com/2008/10/fda-preemption-kleptocrats-neglected-to-mention#comments</comments>
		<pubDate>Thu, 30 Oct 2008 17:02:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bush administration]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[L.A. Times]]></category>
		<category><![CDATA[Mad Magazine]]></category>
		<category><![CDATA[Portland personal injury lawyer]]></category>
		<category><![CDATA[injury]]></category>
		<category><![CDATA[preemption]]></category>
		<category><![CDATA[product safety]]></category>
		<category><![CDATA[sugerman]]></category>
		<category><![CDATA[drug safety]]></category>

		<guid isPermaLink="false">http://www.pspc.com/?p=245</guid>
		<description><![CDATA[I grew up on Mad magazine, and one of my favorite features was &#8220;What they say&#8230;What they really mean.&#8221; And I&#8217;m reminded of that feature with this L.A. Times report on the Food and Drug Administration staff&#8217;s opposition to preemption.
Digression, first off, to credit reader JW on the pithy term &#8220;Kleptocracy&#8221; to describe the current [...]]]></description>
		<wfw:commentRss>http://www.pspc.com/2008/10/fda-preemption-kleptocrats-neglected-to-mention/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Salmonella outbreak: Getting past the &#8220;don&#8217;t eat that&#8221; mentality</title>
		<link>http://www.pspc.com/2008/06/salmonella-outbreak-getting-past-the-dont-eat-that-mentality</link>
		<comments>http://www.pspc.com/2008/06/salmonella-outbreak-getting-past-the-dont-eat-that-mentality#comments</comments>
		<pubDate>Wed, 11 Jun 2008 15:17:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[Portland injury lawyer]]></category>
		<category><![CDATA[attorneys]]></category>
		<category><![CDATA[food safety]]></category>
		<category><![CDATA[injury]]></category>
		<category><![CDATA[sugerman]]></category>
		<category><![CDATA[Portland personal injury lawyer]]></category>
		<category><![CDATA[tomato salmonella outbreak]]></category>

		<guid isPermaLink="false">http://www.pspc.com/?p=178</guid>
		<description><![CDATA[The recent FDA announcement of the tomato salmonella outbreak leads me to wonder about how we got here. Announcements like this give the media great material to play with the fear process. I call it the &#8220;don&#8217;t eat that,&#8221; or scare-of-the-moment journalism. The danger is real, of course, as salmonella can pose a serious health [...]]]></description>
		<wfw:commentRss>http://www.pspc.com/2008/06/salmonella-outbreak-getting-past-the-dont-eat-that-mentality/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vytorin-More Details on Consumer Claims</title>
		<link>http://www.pspc.com/2008/01/vytorin-more-details-on-consumer-claims</link>
		<comments>http://www.pspc.com/2008/01/vytorin-more-details-on-consumer-claims#comments</comments>
		<pubDate>Sun, 27 Jan 2008 15:24:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[Wall Street Journal]]></category>
		<category><![CDATA[consumer]]></category>
		<category><![CDATA[vytorin]]></category>
		<category><![CDATA[class action]]></category>
		<category><![CDATA[deceptive]]></category>
		<category><![CDATA[fraud]]></category>
		<category><![CDATA[unlawful trade practices]]></category>
		<category><![CDATA[utpa]]></category>

		<guid isPermaLink="false">http://www.pspc.com/2008/01/vytorin-more-details-on-consumer-claims</guid>
		<description><![CDATA[For consumers who have taken Vytorin, here&#8217;s a good summary of the problem from the New  York Times: http://www.nytimes.com/2008/01/15/business/15drug.html
Interestingly, the companies have apparently known since April 2006 that their higher-priced drugs were not more effective than generics. But they sat on that information until Congress pressured them to release their study this month.  [...]]]></description>
		<wfw:commentRss>http://www.pspc.com/2008/01/vytorin-more-details-on-consumer-claims/feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>FDA Investigating Vytorin</title>
		<link>http://www.pspc.com/2008/01/fda-investigating-vytorin</link>
		<comments>http://www.pspc.com/2008/01/fda-investigating-vytorin#comments</comments>
		<pubDate>Sun, 27 Jan 2008 00:11:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[consumer]]></category>
		<category><![CDATA[sugerman]]></category>
		<category><![CDATA[vytorin]]></category>
		<category><![CDATA[class action]]></category>
		<category><![CDATA[deceptive]]></category>
		<category><![CDATA[fraud]]></category>
		<category><![CDATA[unlawful trade practices]]></category>
		<category><![CDATA[utpa]]></category>

		<guid isPermaLink="false">http://www.pspc.com/2008/01/fda-investigating-vytorin</guid>
		<description><![CDATA[Coming on the revelations that Vytorin is no more effective than generics, the FDA announced that it would investigate the drug and its manufacturers,Merck &#38; Co Inc. and and Schering-Plough Corp.
Here is the url for more information on FDA action: http://www.msnbc.msn.com/id/22847409/
The press accounts don&#8217;t specify the scope of the investigation, but based upon an earlier [...]]]></description>
		<wfw:commentRss>http://www.pspc.com/2008/01/fda-investigating-vytorin/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zetia and Vytorin Subject of Consumers&#8217; Class Actions</title>
		<link>http://www.pspc.com/2008/01/zetia-and-vytorin-subject-of-consumers-class-actions</link>
		<comments>http://www.pspc.com/2008/01/zetia-and-vytorin-subject-of-consumers-class-actions#comments</comments>
		<pubDate>Sat, 26 Jan 2008 00:26:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[sugerman]]></category>
		<category><![CDATA[vytorin]]></category>

		<guid isPermaLink="false">http://www.pspc.com/2008/01/zetia-and-vytorin-subject-of-consumers-class-actions</guid>
		<description><![CDATA[New studies released earlier this month raise troubling questions about the effectiveness of two prescript medications used to control cholesterol. The generic products Ezetimibe&#8211;marketed under the registered trademark Zetia&#8211;and Ezetimibe/Simvastatin&#8211;marketed under the registered trademark Vytorin&#8211;apparently aren&#8217;t effective, as represented by their manufacturers.
Disclosure: the author of this blog routinely handles consumer class actions and may become [...]]]></description>
		<wfw:commentRss>http://www.pspc.com/2008/01/zetia-and-vytorin-subject-of-consumers-class-actions/feed</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
	</channel>
</rss>
